Company profile: HeartGenetics
1.1 - Company Overview
Company description
- Provider of DNA microchip-based genotyping technology for cardiac genetic diseases, enabling high-throughput and high-accuracy genetic analysis on a DNA Microchip platform optimized with an iPlex MassArray system.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to HeartGenetics
Omega Therapeutics
HQ: United States
Website
- Description: Provider of a proprietary epigenomic programming platform (OMEGA Platform) to develop therapeutics by controlling gene expression; conducts the MYCHELANGELO Phase 1/2 trial in non-small cell lung cancer; runs IND-enabling preclinical studies in inflammation/immunology and other diseases to assess gene targets; and offers an expanded access policy for investigational therapies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Omega Therapeutics company profile →
Adverum Biotechnologies
HQ: United States
Website
- Description: Provider of gene therapy, developing medicines with therapeutic benefits. Offerings include Ixo-vec, a gene therapy product candidate for wet age-related macular degeneration designed for single administration, and the OPTIC clinical program investigating the safety, efficacy, and long-term outcomes of Ixo-vec in wet AMD patients.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Adverum Biotechnologies company profile →
Verogen
HQ: United States
Website
- Description: Provider of tailored next-generation sequencing solutions for forensic laboratories, including the MiSeq FGx Sequencing System (Forensic Genomics and Research Use Only modes); ForenSeq DNA Signature Prep, MainstAY, Kintelligence, and Imagen kits for human identification, kinship, and phenotypic/biogeographical ancestry; and Universal Analysis Software for data management, high-volume analysis, and reporting.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Verogen company profile →
ViroGates
HQ: Denmark
Website
- Description: Provider of suPARnostic blood test products for better triaging in hospitals, primarily used in emergency departments for risk stratification to improve patient care, reduce healthcare costs, and empower clinical staff.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ViroGates company profile →
Parse Biosciences
HQ: United States
Website
- Description: Provider of single-cell sequencing kits and data analysis software for researchers, including Evercode Whole Transcriptome (instrument-free, scalable from thousands to millions of cells), Evercode Immune Profiling (TCR/BCR sequencing), CRISPR Detect (gRNA plus gene expression in up to one million cells), Gene Capture (targeted scRNA-seq panels), and software integrating with NGS platforms.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Parse Biosciences company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for HeartGenetics
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to HeartGenetics
2.2 - Growth funds investing in similar companies to HeartGenetics
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for HeartGenetics
4.2 - Public trading comparable groups for HeartGenetics
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →